Qingxin kaiqiao fang ameliorates memory impairment and inhibits apoptosis in APP/PS1 double transgenic mice through the MAPK pathway

BACKGROUND: Qingxin kaiqiao fang (QKF) has been found to treat Alzheimer’s disease (AD) through apoptosis inhibition. The mitogen-activated protein kinase (MAPK) pathway is closely related to apoptosis in the course of AD. This study aimed to investigate whether QKF-induced apoptosis depression is a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Drug Des Devel Ther
Päätekijät: Gao, Shiyu, Lin, Jianwei, Wang, Tianqi, Shen, Yan, Li, Yan, Yang, Wenyu, Zhou, Kailiang, Hu, Haiyan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350643/
https://ncbi.nlm.nih.gov/pubmed/30774310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S188505
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia